1. Design, Synthesis, and Evaluation of (2-Aminocyclopropyl)phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain
- Author
-
David Alagille, Satoru Matsuda, Rina Baba, Gilles Tamagnan, Thomas J. Morley, Yasushi Hattori, Tatsuki Koike, Caroline Papin, Cristian Constantinescu, Alexandra Gouasmat, Vincent M. Carroll, Shinji Iwasaki, and Kouta Matsumiya
- Subjects
Cyclopropanes ,Male ,Histone H3 Lysine 4 ,animal structures ,Swine ,Contrast Media ,01 natural sciences ,Cell Line ,03 medical and health sciences ,chemistry.chemical_compound ,Histone demethylation ,Drug Discovery ,medicine ,Animals ,Humans ,030304 developmental biology ,Histone Demethylases ,chemistry.chemical_classification ,Flavin adenine dinucleotide ,0303 health sciences ,medicine.diagnostic_test ,biology ,Brain ,Methylation ,Macaca mulatta ,Rats ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Enzyme ,chemistry ,Biochemistry ,Positron emission tomography ,Drug Design ,Positron-Emission Tomography ,biology.protein ,Molecular Medicine ,Demethylase ,Monoamine oxidase A ,Protein Binding - Abstract
Dysregulation of histone H3 lysine 4 (H3K4) methylation is implicated in the pathogenesis of neurodevelopmental disorders. Lysine-specific demethylase 1 (LSD1) determines the methylation status of H3K4 through flavin adenine dinucleotide (FAD)-mediated histone demethylation. Therefore, LSD1 inhibition in the brain can be a novel therapeutic option for treating these disorders. Positron emission tomography (PET) imaging of LSD1 allows for investigating LSD1 expression levels under normal and disease conditions and validating target engagement of therapeutic LSD1 inhibitors. This study designed and synthesized (2-aminocyclopropyl)phenyl derivatives with irreversible binding to LSD1 as PET imaging agents for LSD1 in the brain. We optimized lipophilicity of the lead compound to minimize the risk of nonspecific binding and identified 1e with high selectivity over monoamine oxidase A and B, which are a family of FAD-dependent enzymes homologous to LSD1. PET imaging in a monkey showed a high uptake of [18F]1e to regions enriched with LSD1, indicating its specific binding to LSD1.
- Published
- 2021
- Full Text
- View/download PDF